TGFB1 and TGFB3 were expressed at levels similar to other inflammatory myopathies, while their receptors—particularly those for TGFB2 and TGFB3—were more strongly upregulated in ANCA-negative VM than in other IIM subtypes (Supplementary Fig. S17). This evidence concerns the gene TGFB3 and myopathy.